United States · FDA National Drug Code directory
MnB rLP2086 subfamily B protein
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68594-028_2f176ace-c62d-42c4-e063-6294a90a7b03
- Product NDC
- 68594-028
- Form
- SUSPENSION
- Composition / generic term
- MnB rLP2086 subfamily B protein
- Labeler
- Boehringer Ingelheim RCV GmbH & Co KG
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20141029
- Source listing expiry
- 20261231
Source-listed ingredients
- NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN — .06 mg/.06mg
These values do not establish equivalence or a dose recommendation.
Packages
- 5000 mg in 1 BAG (68594-028-99) · 68594-028-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →